Skip to content
Extreme Investor Network
  • Contact Us
  • Privacy Policy

Kidney

FDA Approves Novo Nordisk’s Ozempic for Treatment of Chronic Kidney Disease

January 29, 2025
Novo Nordisk's Ozempic may lower risk of opioid overdoses: study

Novo Nordisk’s Ozempic Approved to Combat Chronic Kidney Disease: A Game-Changer for Diabetics In a landmark decision, the Food and Drug Administration (FDA) has granted approval for Novo Nordisk’s Ozempic to be used in treating … Read more

Categories Business News Tags approves, Chronic, disease, FDA, Kidney, Nordisks, Novo, Ozempic, Treatment

Categories

Recent Posts

  • Gold Rises as Middle East Tensions EscalateJune 14, 2025
  • Hang Seng Index Update: Trade Deal Optimism Diminishes Amid Israel-Iran Tensions – Weekly ReviewJune 14, 2025
  • Understanding Credit Cycling: How It Works and Its RisksJune 14, 2025
  • Wells Fargo Boosts Outlook on Cloud Security Leader, Forecasts 28% Growth PotentialJune 14, 2025
  • Mirandus June Update: Unveiling New Characters and ChallengesJune 14, 2025
  • Analysis: Trend Hedge Funds Face Challenges as Agile Macro Funds Adapt to Volatile MarketsJune 14, 2025
  • XRP Update: Ripple Anticipates Key Court Decision Amid Growing ETF Excitement Boosting BTCJune 14, 2025
  • BMO Raises Oracle to Outperform After Impressive Earnings ReportJune 14, 2025
  • Insights Gained from Traveling Across Europe with Jensen HuangJune 14, 2025
  • Paxos Secures Approval in Singapore to Launch Stablecoins, Joins Forces with DBS BankJune 14, 2025

Archives

© 2025 Extreme Investor Network

Usermaven | Website analytics and product insights